New study aims to cut opioid use after difficult C-Sections
NCT ID NCT06925152
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a special numbing shot (TAP block) given during a complex C-section can reduce the need for strong painkillers afterward. About 120 women with a history of multiple abdominal surgeries will participate. The goal is to improve pain control and lower opioid use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
About 120 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2025
- Expected to finish
-
May 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 50 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria: Patient has a history of a least one of the following: * Prior exploratory laparotomy * History of non-obstetric open intra-abdominal surgery * History of three or more prior cesarean deliveries * History of intra-abdominal or pelvic adhesive disease * History of abdominoplasty * History of abdominal re-exploration surgery Exclusion Criteria: * Received general anesthesia * History of less than 3 cesarean deliveries if do not meet other inclusion criteria * History of chronic opioid use * History of substance abuse (i.e. alcohol, methamphetamine/amphetamine, abuse of prescription opioid medication, or heroin use) * History of chronic kidney disease * Allergies to bupivacaine or oral analgesics * Patient preference * Cesarean hysterectomy * Administration of ≥4mg morphine to epidural * Loss to follow-up
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cesarean delivery are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Regional One Health
RECRUITINGMemphis, Tennessee, 38103, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new pain drug match morphine for C-Section recovery?
- Could a simple wrist grip ease anxiety during C-Section?
- Could a scent and a touch soothe Post-Surgery pain?
- Finger sensor may read pain and anxiety during c-section
- Which pain block works best after C-Section? new trial aims to find out
- Eye reflex may flag hidden risk in cesarean births